BPC-157/TB-500 Blend vs GHK-Cu
Side-by-side comparison of BPC-157/TB-500 Blend and GHK-Cu: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
BPC-157/TB-500 Blend
GHK-Cu
BPC-157/TB-500 Blend
Combined healing peptide blend
Lowest listed price: $49.99 across 6 listings
Full BPC-157/TB-500 Blend profileGHK-Cu
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a molecule Pickart and Thaler first pulled out of human plasma in 1973. The free peptide (GHK, C14H24N6O4) weighs about 340.4 Da; bind it 1:1…
Lowest listed price: $34.99 across 7 listings
Full GHK-Cu profileSide-by-side comparison
| Attribute | BPC-157/TB-500 Blend | GHK-Cu |
|---|---|---|
| Category | Recovery | Skin, Hair & Aesthetics |
| Research Stage | Preclinical | Approved/marketed as a topical cosmetic ingredient (Copper tripeptide-1) with supporting small human studies. Injectable use is preclinical/off-label, research-use-only, with no human clinical trials. |
| Mechanism of Action | A combination of BPC-157 and TB-500 (thymosin beta-4) in a single formulation. It pairs BPC-157's angiogenic, pro-healing activity - driven largely through VEGFR2 and nitric-oxide (Akt-eNOS) signaling (PMID: 40789979) - with TB-500's actin… | GHK-Cu works mostly as a copper shuttle and a signaling peptide. It binds Cu(II) with high affinity (log K around 16.4, close to albumin's 16.2) and can supply or regulate copper for copper-dependent enzymes like SOD1, lysyl oxidase, cytochrome c oxidase, and… |
| Half-Life | BPC-157: short - under ~30 min in animal PK studies (rats/dogs); no human PK data. TB-500 (thymosin beta-4): active fragment ~30 min, though tissue effects are prolonged. | ~30-60 min (plasma; approximate legacy figure, no robust modern human PK study) |
| Typical Dose Range | Dosed per component (a fixed daily blend over-doses TB-500 - see notes). BPC-157: 250-500 mcg once daily SUBQ. TB-500 (thymosin beta-4): 2-2.5 mg twice weekly during a 4-6 week loading phase, then 2-2.5 mg once weekly for maintenance (~5 mg/week during loading). If a pre-blended fixed-ratio daily vial is used, its TB-500 fraction should be ~250-350 mcg per injection so the weekly TB-500 total stays near ~5 mg. | 200-500 mcg SC daily (community/RUO; no clinically established injectable dose) |
| Dosing Frequency | BPC-157: once daily SUBQ. TB-500: twice weekly during the loading phase, then maintenance ~2-3x/week or once weekly for TB-500 as needed. | Once daily subcutaneous; some run 5 days on / 2 days off. Topical: 1-2x daily to cleansed skin. |
| Administration | Subcutaneous, Intramuscular | Subcutaneous, Topical |
| Side Effects | See individual compounds. Generally well-tolerated. Injection site reactions, mild nausea, headache. Rare: temporary fatigue. | Topical GHK-Cu is generally well tolerated; higher-concentration formulations (4-5%) raise the odds of irritation, redness, or stinging. Injectable use has no safety data from controlled trials; the main theoretical concern is copper accumulation with repeated… |
| Molecular Weight | BPC-157: ~1419.5 g/mol (average; molecular formula C62H98N16O22). TB-500 (thymosin beta-4): ~4963 Da (full 43-residue peptide). | Free peptide (GHK): 340.38 Da (C14H24N6O4). Copper complex (GHK-Cu): 401.9 Da (C14H22CuN6O4, neutral 1:1 Cu(II) complex). |
| Common Vial Sizes | 5mg, 10mg | 50 mg, 100 mg |
Price History
4 data points- OF
- BM
- Half Nattys
- BHG Labs
- RC
Price History
4 data points- OF
- BM
- Half Nattys
- BHG Labs
BPC-157/TB-500 Blend: potential benefits
- Accelerated tissue healing (preclinical/anecdotal)
- Reduced recovery time
- Anti-inflammatory support
- Complementary repair mechanisms: angiogenesis (BPC-157) plus actin-regulated cell migration (TB-500)
GHK-Cu: potential benefits
- Stimulates type I collagen synthesis in human fibroblasts at low nanomolar-to-picomolar concentrations (PMID: 3169264)
- Increases glycosaminoglycans (dermatan/chondroitin sulfate) and upregulates decorin in wound models (PMID: 11121126)
- Modulates matrix metalloproteinases and their inhibitors, partially correcting the MMP-9/TIMP-1 imbalance in a smoke-induced emphysema model (PMID: 35936787)
- Drives tissue remodeling and chemoattracts macrophages, mast cells, and capillary cells to injury sites (PMID: 18644225)
- Modulates expression of ~4,000+ human genes via the Broad Institute Connectivity Map, including DNA-repair and antioxidant genes (PMID: 25302294)
- Increases stemness and proliferative potential of epidermal basal cells and keratinocytes (PMID: 23019153)
- Acts as an antioxidant and anti-inflammatory copper regulator in the context of aging (PMID: 22666519)
- Broad skin-regeneration effects on collagen, proteoglycans, MMPs, and immune/endothelial cell recruitment (PMID: 26236730)
Frequently asked
What's the difference between BPC-157/TB-500 Blend and GHK-Cu?
BPC-157/TB-500 Blend is a recovery that a combination of bpc-157 and tb-500 (thymosin beta-4) in a single formulation. it pairs bpc-157's angiogenic, pro-healing activity - driven largely through vegfr2 and nitric-oxide…. GHK-Cu is a skin, hair & aesthetics that ghk-cu works mostly as a copper shuttle and a signaling peptide. it binds cu(ii) with high affinity (log k around 16.4, close to albumin's 16.2) and can supply or regulate copper…. The two differ in mechanism, half-life (BPC-157: short - under ~30 min in animal PK studies (rats/dogs); no human PK data. TB-500 (thymosin beta-4): active fragment ~30 min, though tissue effects are prolonged. vs ~30-60 min (plasma; approximate legacy figure, no robust modern human PK study)), and typical dose range.
Which has the longer half-life, BPC-157/TB-500 Blend or GHK-Cu?
BPC-157/TB-500 Blend has a half-life of BPC-157: short - under ~30 min in animal PK studies (rats/dogs); no human PK data. TB-500 (thymosin beta-4): active fragment ~30 min, though tissue effects are prolonged.. GHK-Cu has a half-life of ~30-60 min (plasma; approximate legacy figure, no robust modern human PK study). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, BPC-157/TB-500 Blend or GHK-Cu?
Lowest listed price on BodyHackGuide: BPC-157/TB-500 Blend from $49.99, GHK-Cu from $34.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack BPC-157/TB-500 Blend and GHK-Cu?
Stacking depends on mechanism overlap, safety profile, and goals. BPC-157/TB-500 Blend and GHK-Cu should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy BPC-157/TB-500 Blend or GHK-Cu
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks, and every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.